Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$1.21 - $1.5 $29,366 - $36,405
24,270 New
24,270 $30,000
Q1 2023

May 16, 2023

SELL
$1.0 - $2.51 $9,585 - $24,058
-9,585 Reduced 33.96%
18,643 $45,000
Q4 2022

Feb 14, 2023

BUY
$1.16 - $2.42 $32,744 - $68,311
28,228 New
28,228 $40,000
Q2 2022

Aug 15, 2022

SELL
$2.0 - $3.0 $35,352 - $53,028
-17,676 Reduced 44.61%
21,943 $45,000
Q4 2021

Feb 14, 2022

SELL
$3.17 - $4.09 $174,020 - $224,524
-54,896 Reduced 58.08%
39,619 $127,000
Q3 2021

Nov 15, 2021

BUY
$3.01 - $3.77 $152,570 - $191,093
50,688 Added 115.65%
94,515 $335,000
Q2 2021

Aug 11, 2021

SELL
$2.86 - $3.61 $66,188 - $83,546
-23,143 Reduced 34.56%
43,827 $139,000
Q1 2021

May 17, 2021

BUY
$2.61 - $4.08 $56,579 - $88,446
21,678 Added 47.86%
66,970 $230,000
Q4 2020

Feb 16, 2021

BUY
$1.82 - $2.61 $38,429 - $55,110
21,115 Added 87.34%
45,292 $114,000
Q2 2020

Aug 14, 2020

SELL
$2.12 - $3.22 $42,228 - $64,139
-19,919 Reduced 45.17%
24,177 $54,000
Q1 2020

May 15, 2020

BUY
$1.82 - $3.87 $17,133 - $36,432
9,414 Added 27.14%
44,096 $112,000
Q4 2019

Feb 14, 2020

BUY
$2.57 - $3.68 $9,141 - $13,089
3,557 Added 11.43%
34,682 $91,000
Q3 2019

Nov 14, 2019

SELL
$3.01 - $4.0 $35,858 - $47,652
-11,913 Reduced 27.68%
31,125 $112,000
Q2 2019

Aug 16, 2019

BUY
$2.79 - $4.31 $8,523 - $13,167
3,055 Added 7.64%
43,038 $145,000
Q2 2019

Aug 14, 2019

BUY
$2.79 - $4.31 $111,552 - $172,326
39,983 New
39,983 $135,000
Q1 2019

May 15, 2019

SELL
$2.54 - $4.02 $51,013 - $80,737
-20,084 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.46 - $4.2 $17,202 - $29,370
-6,993 Reduced 25.83%
20,084 $56,000
Q3 2018

Nov 14, 2018

BUY
$3.81 - $5.53 $9,174 - $13,316
2,408 Added 9.76%
27,077 $112,000
Q2 2018

Aug 14, 2018

SELL
$5.06 - $6.78 $158,620 - $212,539
-31,348 Reduced 55.96%
24,669 $128,000
Q3 2017

Nov 14, 2017

BUY
$10.45 - $11.44 $585,377 - $640,834
56,017
56,017 $586,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $50.2M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.